cetirizine and s 1743

cetirizine has been researched along with s 1743 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonnabry, P; Combescure, C; Dayer, P; Girardin, F; Haller, G; Huttner, B; Muscionico, D; Salomon, JL; Vernaz, N1
Choi, P; Gellad, WF; Good, CB; Kesselheim, AS; Mizah, M1

Other Studies

2 other study(ies) available for cetirizine and s 1743

ArticleYear
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis.
    PLoS medicine, 2013, Volume: 10, Issue:6

    Topics: Cetirizine; Costs and Cost Analysis; Esomeprazole; Female; Formularies, Hospital as Topic; Health Care Costs; Humans; Male; Marketing; Middle Aged; Nonprescription Drugs; Patents as Topic; Prescription Drugs; Residence Characteristics; Time Factors

2013
Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011.
    The American journal of managed care, 2014, Mar-01, Volume: 20, Issue:3

    Topics: Antidotes; Azabicyclo Compounds; Benzhydryl Compounds; Bronchodilator Agents; Central Nervous System Stimulants; Cetirizine; Dexlansoprazole; Dexmethylphenidate Hydrochloride; Drug Approval; Drug Prescriptions; Drugs, Generic; Esomeprazole; Eszopiclone; Ethanolamines; Formoterol Fumarate; Histamine H1 Antagonists, Non-Sedating; Humans; Hypnotics and Sedatives; Levoleucovorin; Medicaid; Modafinil; Patents as Topic; Piperazines; Proton Pump Inhibitors; Retrospective Studies; Stereoisomerism; United States; United States Food and Drug Administration; Wakefulness-Promoting Agents

2014